Wei Guo Shao-Chun Guo Min Li Li-Hong Li Yan Qu
10.1186/s13756-018-0313-5
Antimicrob Resist Infect Control
2018 Feb 14;7:22.
acinetobacter baumannii intraventricular therapy multidrug resistance polymyxin b ventriculitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/29456841/
Acinetobacter baumannii / drug effects Cerebral Ventriculitis / drug therapy Drug Resistance, Multiple, Bacterial / drug effects Polymyxin B / therapeutic use Tigecycline / therapeutic use
Acinetobacter baumannii / drug effects Cerebral Ventriculitis / drug therapy Drug Resistance, Multiple, Bacterial / drug effects Polymyxin B / therapeutic use Tigecycline / therapeutic use Case Reports Acinetobacter baumannii / pathogenicity Administration, Intravenous Anti-Bacterial Agents / administration & dosage Anti-Bacterial Agents / therapeutic use Blood-Brain Barrier Brain Injuries / complications Brain Injuries / diagnostic imaging Cerebral Ventriculitis / diagnostic imaging Cerebral Ventriculitis / microbiology China Drug Combinations Humans Male Meningitis, Bacterial / drug therapy Middle Aged Polymyxin B / administration & dosage Tigecycline / administration & dosage Tomography, X-Ray Computed Anti-Bacterial Agents Drug Combinations Tigecycline Polymyxin B
PMC5813425
29456841
Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
2018